Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Community-acquired pneumonia in children.

× No keyword cloud information.

153 in total

1. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.

Authors: Fei Zhao; Min Lv; Xiaoxia Tao; Hui Huang; Binghua Zhang; Zhen Zhang; Jianzhong Zhang
Journal: Antimicrob Agents Chemother Date: 2011-11-21 Impact factor: 5.191

2. Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland.

Authors: M Patrzałek; P Albrecht; M Sobczynski
Journal: Eur J Clin Microbiol Infect Dis Date: 2010-05-01 Impact factor: 3.267

3. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.

Authors: Carlos G Grijalva; J Pekka Nuorti; Yuwei Zhu; Marie R Griffin
Journal: Clin Infect Dis Date: 2010-03-15 Impact factor: 9.079

4. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.

Authors: Chonnamet Techasaensiri; Claudia Tagliabue; Marianna Cagle; Pooya Iranpour; Kathy Katz; Thirumalai R Kannan; Jacqueline J Coalson; Joel B Baseman; R Doug Hardy
Journal: Am J Respir Crit Care Med Date: 2010-05-27 Impact factor: 21.405

5. Identification of bacterial pathogens in pediatric community-acquired lower respiratory tract infection using a simplified procedure of sputum sampling and examination: comparison between hospitalized children with and without underlying diseases.

Authors: T Hoshina; K Kusuhara; T Takimoto; M Saito; T Hara
Journal: Eur J Clin Microbiol Infect Dis Date: 2010-02-24 Impact factor: 3.267

6. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.

Authors: Miyuki Morozumi; Keiko Hasegawa; Reiko Kobayashi; Nagako Inoue; Satoshi Iwata; Haruo Kuroki; Naohisa Kawamura; Eiichi Nakayama; Takeshi Tajima; Kouichi Shimizu; Kimiko Ubukata
Journal: Antimicrob Agents Chemother Date: 2005-06 Impact factor: 5.191

Community-acquired pneumonia in children.

1. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.

2. Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland.

3. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.

4. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.

5. Identification of bacterial pathogens in pediatric community-acquired lower respiratory tract infection using a simplified procedure of sputum sampling and examination: comparison between hospitalized children with and without underlying diseases.

6. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.

7. Simplified semiquantitative culture using washed sputum from children with lower respiratory tract infections.

8. Quick identification of febrile neonates with low risk for serious bacterial infection: an observational study.

9. Pneumonia: macrolides or amoxicillin for community acquired pneumonia?

10. Comparison of two antibiotic regimens in the empirical treatment of severe childhood pneumonia.